Stockscreener 앱 받기
1.33
8.90%
-0.13
시장 영업 전:
1.35
0.02
+1.50%
Tevogen Bio Holdings Inc 주식(TVGN)의 최신 뉴스
UPDATETevogen Founder Reflects on Importance of - GlobeNewswire
Tevogen Founder Reflects on Importance of Preserving - GlobeNewswire
Tevogen Bio Achieves $40M Cost Efficiency While Building Biotech Portfolio | TVGN Stock News - StockTitan
Tevogen Bio Shares Are On The Rise Monday: What's Going On? - Benzinga
Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in Healthcare - Yahoo Finance
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations - The Manila Times
Tevogen Bio Nears Finalization of Agreement to Enhance R&D - GlobeNewswire
Tevogen Bio Secures $36M Credit Line, Expands Manufacturing With Strategic Deal | TVGNW Stock News - StockTitan
Tevogen Bio partners Microsoft for HPV treatment - Yahoo! Voices
Tevogen Bio Holdings Inc (TVGN-Q) QuotePress Release - The Globe and Mail
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability - The Manila Times
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigio - WICZ
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability - GlobeNewswire
TVGNTevogen Bio Holdings Inc. Latest Stock News & Market Updates - StockTitan
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920 - The Manila Times
Tevogen Bio advances HPV oncology treatment TVGN 920 By Investing.com - Investing.com UK
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine L - WICZ
Tevogen Bio Teams with Microsoft AI to Fast-Track HPV Cancer Treatment Development | TVGN Stock News - StockTitan
Tevogen Bio Announces Appointment of Anthony Tarantino as - GlobeNewswire
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support - Yahoo Finance
Tevogen Bio Holdings Inc. Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs - Marketscreener.com
Tevogen partners with Microsoft to speed up drug development By Investing.com - Investing.com Australia
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs - The Manila Times
Tevogen Bio Expands on Microsoft Partnership to Integrate - GlobeNewswire
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company - The Manila Times
Tevogen Bio Reports Nasdaq Listing Compliance as CEO - GlobeNewswire
Tevogen Bio Signs Letter of Intent With CD8 Technology to - GlobeNewswire
Tevogen Bio plans new R&D and manufacturing facility By Investing.com - Investing.com UK
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity - StockTitan
Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market SessionKoninklijke Philips (NYSE:PHG) - Benzinga
Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas - ForexTV.com
Tevogen Bio Provides Additional Guidance on Introduction of - GlobeNewswire
Tevogen Bio (NASDAQ:TVGN) Shares Gap DownShould You Sell? - MarketBeat
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Up 450.9% in October - MarketBeat
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Tevogen Bio Shares Are Soaring Wednesday: What's Going On? - MSN
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Tevogen Bio's Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - The Manila Times
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen - GlobeNewswire
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - StockTitan
Tevogen Bio To Provide Timelines Associated with Recently - GlobeNewswire
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week - GlobeNewswire Inc.
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy - GlobeNewswire
Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion - The Manila Times
Tevogen Bio Specialty Care Reports Top-Line Revenue - GlobeNewswire
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days - StockTitan
Teucrium Wheat (WEAT-A) QuotePress Release - The Globe and Mail
Insider Selling: Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells 1,078,600 Shares of Stock - MarketBeat
20% Of This Tevogen Bio Holdings Insider's Holdings Were Sold - Simply Wall St
Tevogen says CSO share sale ‘solely’ to satisfy payment of tax obligations - TipRanks
Tevogen bio holdings chief scientific officer sells shares worth $1.75 million - Investing.com UK
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days - ForexTV.com
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company's Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days - The Manila Times
3.66%
1.11%
자본화:
|
볼륨(24시간):